Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilate for Heavy Menstrual Bleeding in Von Willebrand Disease
NCT06205095Phase 3Recruiting
- Sponsor
- Unity Health Toronto
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Unity Health Toronto. Started Oct 2024; status: recruiting.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT06205095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205095.